Comparison of direct thrombin inhibitors versus low molecular weight heparins for the prevention of venous thromboembolism in patients with Staphylococcus aureus bacteraemia.
Phase 1
- Conditions
- staphylococcus aureus bacteraemiaTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- EUCTR2012-004863-29-BE
- Lead Sponsor
- niversity Hospitals Leuven (Gasthuisberg)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Positive blood culture for staphylococcus aureus in an adult patient with symptoms or signs of infection.
Indication for thromboprophylaxis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
Contraindication for thromboprophylaxis.
Clinically significant active bleeding or risk of excessive bleeding.
Heparin-induced thrombocytopenia.
Severe liver and kidney disease.
Pregnancy and lactation.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method